Product: GLP-1 (Glucagon-Like Peptide-1) - 6mg Research Grade
Discover the cutting-edge potential of GLP-1 peptides for your research applications. Our premium-grade GLP-1 peptide represents one of the most significant breakthroughs in metabolic and diabetes research, offering researchers unprecedented opportunities to explore innovative therapeutic pathways.
Research Applications & Mechanisms:
GLP-1 operates through sophisticated glucose-dependent mechanisms, activating G-protein-coupled receptors to stimulate insulin secretion while simultaneously inhibiting glucagon release. This dual-action approach makes it invaluable for research into:
Metabolic Homeostasis Studies: Investigation of glucose regulation and insulin sensitivity pathways
Cardiovascular Research: Exploring cardioprotective effects and heart failure prevention mechanisms
Neuroprotection Studies: Research into Alzheimer's, Parkinson's, and other neurodegenerative conditions
Weight Management Research: Understanding appetite suppression and energy expenditure mechanisms
Renal Function Studies: Investigating nephroprotective effects and kidney disease prevention
Advanced Research Benefits:
Our GLP-1 peptide demonstrates remarkable versatility in research applications. Studies indicate that GLP-1 activates the cAMP-PKA pathway, promoting insulin secretion from pancreatic β-cells while inhibiting glucagon from α-cells through paracrine somatostatin-dependent mechanisms. This makes it essential for researchers investigating incretin biology and metabolic disorders.
The peptide's ability to delay gastric emptying and reduce food intake through central nervous system pathways offers unique opportunities for obesity and eating behavior research. Additionally, emerging evidence suggests GLP-1's potential in reducing inflammation, oxidative stress, and providing neuroprotective benefits.
Quality Specifications:
Purity: >95% by HPLC analysis
Molecular Weight: 3297.7 g/mol
Storage: Store at -20°C for optimal stability
Solubility: Reconstitute in sterile water or appropriate buffer
Analytical Methods: Verified by HPLC-MS for sequence confirmation and purity assessment
Research-Grade Excellence:
Our GLP-1 peptide undergoes rigorous analytical characterization including reversed-phase HPLC, mass spectrometry analysis, and comprehensive impurity profiling. Each batch is tested for sequence verification, molecular weight confirmation, and stability to ensure consistent research results.
The peptide demonstrates excellent stability when properly stored and exhibits reliable biological activity in cellular assays. Quality control measures include detection of potential impurities such as truncated sequences, oxidation products, and deamidated variants.
Innovative Research Opportunities:
GLP-1's multi-target effects make it invaluable for investigating:
Incretin biology and glucose homeostasis
Beta-cell preservation and regeneration
Cardiovascular protection mechanisms
Neural signaling pathways
Metabolic syndrome interventions
Anti-inflammatory pathways
Professional Research Support:
Ideal for pharmaceutical research, academic studies, and biotechnology applications. Our GLP-1 peptide supports investigations into next-generation therapeutic approaches, from traditional diabetes research to cutting-edge applications in neurodegeneration and cardiovascular health.
Important Notice:
This product is intended for research use only. Not for human consumption or therapeutic use. Proper laboratory safety protocols should be followed when handling this research material.
Technical Specifications:
Sequence: Native human GLP-1 (7-37)
Appearance: White to off-white lyophilized powder
pH: 4-6 when reconstituted
Endotoxin Level: <1.0 EU/mg
Advance your metabolic research with confidence using our premium GLP-1 peptide - where scientific excellence meets research innovation.
Semaglutide 6mg
- Typical dosages can range, but commonly it’s 2mg per vial, which can be reconstituted with sterile water.
- The peptide is typically administered via subcutaneous injection.
- The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component).
- As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
- It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.